Profil
David L.
Lucchino was the founder of Semprus BioSciences Corp., serving as President, Chief Executive Officer & Director from 2005 to 2012.
Mr. Lucchino was the founder of Frequency Therapeutics, Inc., serving as President, CEO, Secretary & Director from 2014 to 2023.
Mr. Lucchino is also the founder of Lauchcyte.
Mr. Lucchino is currently President & Chief Executive Officer at Brenig Therapeutics, Inc. since 2025, Director at The Multiple Myeloma Research Foundation, Inc., Director at National Outdoor Leadership School, and Member-College of Fellows at American Institute For Medical & Biological Engineering.
Former positions include President & Chief Executive Officer at Entrega, Inc. from 2014 to 2016, Chairman at Massachusetts Biotechnology Council, Director at Lipella Pharmaceuticals, Inc., Director at Advanced Medical Technology Association, Independent Director at Korro Bio, Inc. from 2023 to 2024, Senior Associate at Polaris Growth Management LLC from 2005 to 2007, and Trustee at Mount Auburn Hospital from 2007 to 2021.
Education includes an undergraduate degree from Denison University in 1991, an MBA from MIT Sloan School of Management in 2006, and a graduate degree from S.I.
Newhouse School of Public Communications in 1997.
Postes actifs de David Lucchino
| Sociétés | Poste | Début |
|---|---|---|
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Directeur/Membre du Conseil | - |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical & biological engineering | Corporate Officer/Principal | - |
National Outdoor Leadership School
National Outdoor Leadership School Miscellaneous Commercial ServicesCommercial Services Operates as wilderness school and provides grant making services | Directeur/Membre du Conseil | - |
Anciens postes connus de David Lucchino
| Sociétés | Poste | Fin |
|---|---|---|
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Directeur Général | 30/10/2025 |
| KORRO BIO, INC. | Fondateur | 01/11/2023 |
Mount Auburn Hospital
Mount Auburn Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Directeur/Membre du Conseil | 01/01/2021 |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/06/2016 |
Formation de David Lucchino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes | Health Technology |
Semprus BioSciences Corp.
Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Develops medical devices for anti-microbial coating to reduce bloodstream infections | Health Technology |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Finance |
Denison University
Denison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Medical Technology Association
Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association that offers information on philanthropy, blood products, diagnostics, orthopedics, ophthalmic, wound care and disaster preparedness | Commercial Services |
Mount Auburn Hospital
Mount Auburn Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Commercial Services |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical & biological engineering | Commercial Services |
National Outdoor Leadership School
National Outdoor Leadership School Miscellaneous Commercial ServicesCommercial Services Operates as wilderness school and provides grant making services | Commercial Services |
Lauchcyte | |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
S.I. Newhouse School of Public Communications
S.I. Newhouse School of Public Communications Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
















